vs
BICYCLE THERAPEUTICS PLC（BCYC）与牛津地产（IIPR）财务数据对比。点击上方公司名可切换其他公司
牛津地产的季度营收约是BICYCLE THERAPEUTICS PLC的1.4倍（$66.7M vs $48.0M），牛津地产净利率更高（47.8% vs -42.0%，领先89.8%），BICYCLE THERAPEUTICS PLC同比增速更快（1193.3% vs -13.1%），过去两年BICYCLE THERAPEUTICS PLC的营收复合增速更高（56.7% vs -6.0%）
Bicycle Therapeutics是一家临床阶段生物制药企业，专注于开发双环肽类创新疗法以解决未被满足的医疗需求，核心管线覆盖肿瘤、罕见病与免疫疾病领域，在欧美布局运营，与全球头部药企达成战略合作推进候选药物落地。
牛津地产是一家加拿大跨国企业，业务涵盖房地产投资、开发与物业管理。其投资组合包含写字楼、零售、工业、多户住宅、生命科学及酒店类资产。该公司1960年以私营企业形式创立，自2003年起成为安大略省市政雇员退休系统（OMERS）的全资子公司，总部设于多伦多，在纽约、伦敦、澳大利亚、新加坡及卢森堡均设有区域总部。
BCYC vs IIPR — 直观对比
营收规模更大
IIPR
是对方的1.4倍
$48.0M
营收增速更快
BCYC
高出1206.4%
-13.1%
净利率更高
IIPR
高出89.8%
-42.0%
两年增速更快
BCYC
近两年复合增速
-6.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $48.0M | $66.7M |
| 净利润 | $-20.2M | $31.8M |
| 毛利率 | — | — |
| 营业利润率 | -51.5% | 47.8% |
| 净利率 | -42.0% | 47.8% |
| 营收同比 | 1193.3% | -13.1% |
| 净利润同比 | 61.1% | -20.4% |
| 每股收益（稀释后） | $-0.29 | $1.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCYCIIPR
| Q4 25 | $48.0M | $66.7M | ||
| Q3 25 | $11.7M | $64.7M | ||
| Q2 25 | $2.9M | $62.9M | ||
| Q1 25 | $10.0M | $71.7M | ||
| Q4 24 | $3.7M | $76.7M | ||
| Q3 24 | $2.7M | $76.5M | ||
| Q2 24 | $9.4M | $79.8M | ||
| Q1 24 | $19.5M | $75.5M |
净利润BCYCIIPR
| Q4 25 | $-20.2M | $31.8M | ||
| Q3 25 | $-59.1M | $29.3M | ||
| Q2 25 | $-79.0M | $26.0M | ||
| Q1 25 | $-60.8M | $31.1M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | $-50.8M | $40.2M | ||
| Q2 24 | $-39.8M | $42.0M | ||
| Q1 24 | $-26.6M | $39.4M |
营业利润率BCYCIIPR
| Q4 25 | -51.5% | 47.8% | ||
| Q3 25 | -558.6% | 45.5% | ||
| Q2 25 | -2965.8% | 45.9% | ||
| Q1 25 | -703.7% | 47.4% | ||
| Q4 24 | — | 54.7% | ||
| Q3 24 | -2385.9% | 54.8% | ||
| Q2 24 | -498.3% | 53.1% | ||
| Q1 24 | -162.4% | 55.7% |
净利率BCYCIIPR
| Q4 25 | -42.0% | 47.8% | ||
| Q3 25 | -503.7% | 45.3% | ||
| Q2 25 | -2703.8% | 41.4% | ||
| Q1 25 | -608.9% | 43.3% | ||
| Q4 24 | — | 52.2% | ||
| Q3 24 | -1898.4% | 52.6% | ||
| Q2 24 | -425.3% | 52.6% | ||
| Q1 24 | -136.0% | 52.3% |
每股收益（稀释后）BCYCIIPR
| Q4 25 | $-0.29 | $1.07 | ||
| Q3 25 | $-0.85 | $0.97 | ||
| Q2 25 | $-1.14 | $0.86 | ||
| Q1 25 | $-0.88 | $1.03 | ||
| Q4 24 | — | $1.35 | ||
| Q3 24 | $-0.74 | $1.37 | ||
| Q2 24 | $-0.77 | $1.44 | ||
| Q1 24 | $-0.62 | $1.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $628.1M | $47.6M |
| 总债务越低越好 | — | $393.7M |
| 股东权益账面价值 | $610.0M | $1.8B |
| 总资产 | $717.6M | $2.4B |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资BCYCIIPR
| Q4 25 | $628.1M | $47.6M | ||
| Q3 25 | $648.3M | $41.9M | ||
| Q2 25 | $721.5M | $104.9M | ||
| Q1 25 | $793.0M | $133.3M | ||
| Q4 24 | $879.5M | $151.2M | ||
| Q3 24 | $890.9M | $172.4M | ||
| Q2 24 | $961.4M | $160.9M | ||
| Q1 24 | $457.0M | $173.5M |
总债务BCYCIIPR
| Q4 25 | — | $393.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $30.9M | — | ||
| Q1 24 | $30.8M | — |
股东权益BCYCIIPR
| Q4 25 | $610.0M | $1.8B | ||
| Q3 25 | $618.5M | $1.9B | ||
| Q2 25 | $668.9M | $1.9B | ||
| Q1 25 | $740.3M | $1.9B | ||
| Q4 24 | $793.1M | $1.9B | ||
| Q3 24 | $831.0M | $1.9B | ||
| Q2 24 | $873.8M | $1.9B | ||
| Q1 24 | $356.0M | $2.0B |
总资产BCYCIIPR
| Q4 25 | $717.6M | $2.4B | ||
| Q3 25 | $764.0M | $2.3B | ||
| Q2 25 | $832.2M | $2.3B | ||
| Q1 25 | $883.9M | $2.4B | ||
| Q4 24 | $956.9M | $2.4B | ||
| Q3 24 | $996.7M | $2.4B | ||
| Q2 24 | $1.1B | $2.4B | ||
| Q1 24 | $547.1M | $2.4B |
负债/权益比BCYCIIPR
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.04× | — | ||
| Q1 24 | 0.09× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.3M | $198.2M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | — |
| 自由现金流率自由现金流/营收 | -41.5% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | — | 6.22× |
| 过去12个月自由现金流最近4个季度 | $-252.0M | — |
8季度趋势，按日历期对齐
经营现金流BCYCIIPR
| Q4 25 | $-19.3M | $198.2M | ||
| Q3 25 | $-71.2M | $45.6M | ||
| Q2 25 | $-72.8M | $48.4M | ||
| Q1 25 | $-86.4M | $54.2M | ||
| Q4 24 | $-164.7M | $258.4M | ||
| Q3 24 | $-39.8M | $64.9M | ||
| Q2 24 | $-44.6M | $64.2M | ||
| Q1 24 | $-70.9M | $71.6M |
自由现金流BCYCIIPR
| Q4 25 | $-19.9M | — | ||
| Q3 25 | $-71.8M | — | ||
| Q2 25 | $-73.3M | — | ||
| Q1 25 | $-87.0M | — | ||
| Q4 24 | $-166.0M | — | ||
| Q3 24 | $-40.3M | — | ||
| Q2 24 | $-45.0M | — | ||
| Q1 24 | $-70.9M | — |
自由现金流率BCYCIIPR
| Q4 25 | -41.5% | — | ||
| Q3 25 | -612.3% | — | ||
| Q2 25 | -2509.7% | — | ||
| Q1 25 | -871.7% | — | ||
| Q4 24 | -4475.7% | — | ||
| Q3 24 | -1504.7% | — | ||
| Q2 24 | -481.2% | — | ||
| Q1 24 | -362.9% | — |
资本支出强度BCYCIIPR
| Q4 25 | 1.2% | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 17.1% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | 16.3% | — | ||
| Q2 24 | 4.5% | — | ||
| Q1 24 | 0.1% | — |
现金转化率BCYCIIPR
| Q4 25 | — | 6.22× | ||
| Q3 25 | — | 1.56× | ||
| Q2 25 | — | 1.86× | ||
| Q1 25 | — | 1.75× | ||
| Q4 24 | — | 6.46× | ||
| Q3 24 | — | 1.61× | ||
| Q2 24 | — | 1.53× | ||
| Q1 24 | — | 1.82× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
